BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10582438)

  • 1. [Acute cardiotoxicity from 5-fluorouracil: un underestimated toxicity].
    Bertolini A; Fiumanò M; Muffatti A; Pedroncelli S; Doria A; Codazzi G; Giustiniani S; Scarinci A; Redaelli G
    Minerva Cardioangiol; 1999; 47(7-8):269-73. PubMed ID: 10582438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiotoxicity of 5-fluorouracil.
    Collins C; Weiden PL
    Cancer Treat Rep; 1987; 71(7-8):733-6. PubMed ID: 3300968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiotoxicity of 5-fluorouracil].
    Teixeira L; Barry S; Debourdeau P; Cohen A; Tournigand C
    Bull Cancer; 2004 Nov; 91 Suppl 3():154-8. PubMed ID: 15899622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin-1 and 5-fluorouracil-induced cardiotoxicity.
    Porta C; Moroni M; Ferrari S; Nastasi G
    Neoplasma; 1998; 45(2):81-2. PubMed ID: 9687887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiotoxicity of de Gramont's regimen: incidence, clinical characteristics and long-term follow-up.
    Meydan N; Kundak I; Yavuzsen T; Oztop I; Barutca S; Yilmaz U; Alakavuklar MN
    Jpn J Clin Oncol; 2005 May; 35(5):265-70. PubMed ID: 15855175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of a novel oral formation of 5-fluorouracil in combination with low-dose cisplatin as preoperative chemotherapy of oral squamous cell carcinoma.
    Nakazawa M; Ohnishi T; Ohmae M; Chisoku H; Yui S; Iwai S; Sumi T; Fukuda Y; Kishino M; Yura Y
    Int J Clin Pharmacol Res; 2005; 25(3):115-22. PubMed ID: 16366419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute heart failure after treatment with 5-fluorouracil.
    Georgieva S; Kinova E; Iordanov V; Gudev A; Tzekova V; Velikova M
    J BUON; 2007; 12(1):113-6. PubMed ID: 17436411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiotoxicity induced by 5-fluorouracil. Review of the literature].
    Blázquez Encinar JC; Martín Jiménez M; Díaz-Rubio García E; Almenarez J
    Rev Clin Esp; 1989 Mar; 184(5):249-51. PubMed ID: 2672149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III].
    Bustová I
    Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant docetaxel, cisplatin and 5-fluorouracil (TPF) in locally advanced squamous cell carcinoma of the head and neck.
    Baghi M; Hambek M; May A; Radeloff A; Gstoettner W; Knecht R
    Anticancer Res; 2006; 26(1B):559-63. PubMed ID: 16739320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiotoxicity of 5-fluorouracil: report of 6 cases].
    Timour Q; Lombard-Bohas C; Slim R; Barel C; Bui-Xuan B; Tabib A; Bricca G; Malonne H; Vial T; Iordescu D; Descotes J
    Therapie; 2002; 57(3):302-6. PubMed ID: 12422546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combination chemotherapy with nedaplatin and 5-fluorouracil for oral squamous cell carcinomas].
    Yamaoka K; Fukuda M; Kuwajima S; Hagiwara H; Toshima S; Matsuoka A; Ohnuki T; Seki H; Nagai H; Iino M; Sageshima M
    Gan To Kagaku Ryoho; 2003 Jul; 30(7):951-5. PubMed ID: 12894709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination chemotherapy with nedaplatin (CDGP) and 5-FU for oral cancer].
    Maruoka Y; Ando T; Hoshino M; Ogiuchi Y; Nishihara N; Okamoto T; Fukada K; Kuwazawa T; Ogiuchi H
    Gan To Kagaku Ryoho; 2002 Mar; 29(3):421-5. PubMed ID: 11915732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiotoxicity of 5-fluorouracil. Spasm or direct myocardial toxicity?].
    Thyss A; Falewee MN; Leborgne L; Viens P; Schneider M; Demard F
    Bull Cancer; 1987; 74(4):381-5. PubMed ID: 3663962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiotoxicity of 5-fluorouracil. Clinical picture of 4 cases and a prevention proposal].
    Bourgeois H; Perault MC; Raud-Raynier P; Favrelière S; Daban A; Vandel B
    Therapie; 1993; 48(3):255-8. PubMed ID: 8140566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiotoxicity of 5-fluorouracil in 1350 patients with no prior history of heart disease.
    Tsibiribi P; Descotes J; Lombard-Bohas C; Barel C; Bui-Xuan B; Belkhiria M; Tabib A; Timour Q
    Bull Cancer; 2006 Mar; 93(3):E27-30. PubMed ID: 16567310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of acute cardiotoxicity from the combination cyclophosphamide-mitoxantrone-5-fluorouracil (CMF) with Holter ECG].
    Doria G; Cangemi F; Tosto A; Platania F; Circo A; Motta S; Tralongo P; Aiello RA; Failla G
    Minerva Cardioangiol; 1990 May; 38(5):223-6. PubMed ID: 2234455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Possible cardiotoxicity induced by orally administered fluoropyrimidines].
    Camps C; Godes M; Soler JJ
    An Med Interna; 1990 Oct; 7(10):525-7. PubMed ID: 2104099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-FU-induced peripheral neuropathy: a rare complication of a well-known drug.
    van Laarhoven HW; Verstappen CC; Beex LV; Kappelle AC; Punt CJ
    Anticancer Res; 2003; 23(1B):647-8. PubMed ID: 12680161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of late-onset severe cardiotoxicity from 5-fluorouracil therapy resulting in death.
    Wijesinghe N
    N Z Med J; 2007 Nov; 120(1266):U2836. PubMed ID: 18264205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.